US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Ascletis Pharma Inc (PK) (ASCLF) 銘柄情報

Ascletis Pharma Inc (PK) (ASCLF)

1.35

0.00

(0.00%)

終了 6月26日 5:00AM

Ascletis Pharma Inc (PK) (ASCLF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

1.35

( - )

買値

0.01

売値

258,001.52

出来高

-

0.00 日の範囲 0.00

1.145 52 週間の範囲 2.50

時価総額

前日終値

1.35

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 2,540,003

発行済株式数

991,874,320

配当利回り

PER

-23.35

1 株当たり利益 (EPS)

-0.37

歳入

2.03M

純利益

-359.88M

Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It... Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China. The company’s commercial products include Ritonavir tablet; and ASCLEVIR and GANOVO for use in the treatment of Hepatitis C virus. It is also developing ASC22 for treating CHB and HIV functional cure; ASC10 for treating respiratory syncytia virus; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, and ASC43F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma; ASC61 for advanced solid tumors; and ASC40, an oral small molecule for the treatment of acne. Further, it offers ASC30, for obesity; ASC47 for muscle-preserving weight loss treatment; and ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist. Ascletis Pharma Inc. was founded in 2013 and is based in Wan Chai, Hong Kong. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.ascletis.com

本社

Wan Chai, Hong Kong

設立

2026

Ascletis Pharma Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker ASCLF. The last closing price for Ascletis Pharma (PK) was US$1.35. Over the last year, Ascletis Pharma (PK) shares have traded in a share price range of US$ 1.145 to US$ 2.50.

Ascletis Pharma (PK) currently has 991,874,320 shares in issue. The market capitalisation of Ascletis Pharma (PK) is US$1.34 billion. Ascletis Pharma (PK) has a price to earnings ratio (PE ratio) of -23.35.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0.03	2.27272727273	1.32	1.35	1.32	1500	1.33	CS
12	-0.87	-39.1891891892	2.22	2.5	1.32	2122	1.99978028	CS
26	-0.135	-9.09090909091	1.485	2.5	1.32	2761	1.8757746	CS
52	0.095	7.56972111554	1.255	2.5	1.145	2558	1.69803644	CS
156	1.1121	467.465321564	0.2379	2.5	0.1402	3382	0.9718863	CS
260	0.21	18.4210526316	1.14	2.5	0.0021	3173	0.83897106	CS

ASCLF - Frequently Asked Questions (FAQ)

What is the current Ascletis Pharma Inc (PK) share price?

The current share price of Ascletis Pharma Inc (PK) is US$ 1.35

How many Ascletis Pharma Inc (PK) shares are in issue?

Ascletis Pharma Inc (PK) has 991,874,320 shares in issue

What is the market cap of Ascletis Pharma Inc (PK)?

The market capitalisation of Ascletis Pharma Inc (PK) is USD 1.34B

What is the 1 year trading range for Ascletis Pharma Inc (PK) share price?

Ascletis Pharma Inc (PK) has traded in the range of US$ 1.145 to US$ 2.50 during the past year

What is the PE ratio of Ascletis Pharma Inc (PK)?

The price to earnings ratio of Ascletis Pharma Inc (PK) is -23.35

What is the cash to sales ratio of Ascletis Pharma Inc (PK)?

The cash to sales ratio of Ascletis Pharma Inc (PK) is 4.52k

What is the registered address of Ascletis Pharma Inc (PK)?

The registered address for Ascletis Pharma Inc (PK) is Dah Sing Financial Centre, Wan Chai

What is the Ascletis Pharma Inc (PK) website address?

The website address for Ascletis Pharma Inc (PK) is www.ascletis.com

Which industry sector does Ascletis Pharma Inc (PK) operate in?

Ascletis Pharma Inc (PK) operates in the Biotechnology & Life Sciences sector

TightCoil

TightCoil 5分前

Easy to Understand, possible reasons include,
1. A good number of foreigners working at SEC
2. Unparalleled, and Massive Staff Incompetence
3. Good number of Self-Dealing insider Activity
4. KIckbacks to Look The Other Way

ListenToTheTrees

ListenToTheTrees 6分前

One thing I think gets overlooked in emerging markets is that the biggest opportunities rarely announce themselves clearly in the beginning. They usually look early, messy, incomplete, and misunderstood. They often come with shifting strategies, regulatory questions, fragmented technology, evolving

Waynewayne

Waynewayne 7分前

When this thing happens and it’s going to there’s gonna be some sad puppy’s on here I can’t wait!

wronginvestor

wronginvestor 7分前

Having worked at a bank they normally hand this kind of thing over to a third party who will decide if there is anything to go after.

Once the appeal fails Hiru will effectively be dead. They will have an $6 million liability accruing interest. They will no longer be debt free and t

mick

UPTICK AT CLOSE

tdbowieknife

tdbowieknife 8分前

Yes... Everything about American Fusion points directly to an insider enrichment scam selling worthless stock to the gullible.

.

.

Watch your wallet

Buyer Beware
Social Media Promoted Frontload Pump a

ORCA

THAT OLD POS.WAS CALLING ME NAMES,AND I DID NOT KNOW WHAT I WAS TALKING ABOUT,AND AGAIN I SEND HIM THE SELLS
WHAT A STUPID IDIOT.UNREAL.I HAD TO SHOW HIM SEVERAL TIMES TO GET IT
THESE ARE SELLS THAT ALREADY HAPPENED,YOU F$CKING IDIOT.READ YOU STUPID F$CK.BUYS AND SELLS.
https://

Steady_T

Steady_T 10分前

If the speculation points toward the MAA still not satisfying MHRA after 2.5 years, it is called reality.
Obvious.

If the speculation points toward approval being imminent, it is called reasonable analysis.
Reasonable maybe.

If there were clear failure is

Aquahoya

Aquahoya 12分前

Pittsburgh Boy

Pittsburgh Boy 14分前

Keep bringing it down cause I'm looking to buy more, thank you.

iron-eagle

iron-eagle 15分前

But it’s dead right?

I mean if you consider BioAmber Inc.'s LEI updating with all new values yesterday as being "dead"...

I guess that's on you.

Also the asset class changed to "Equity / International Developed" - can you enlighten us on that change? I'

Timing101

Timing101 15分前

$CRCW Have not looked here in some time since Ron Levy had so Many PR's , New Advisors last year which never , EVER (as usual RON)
ever materialized.
--
I see he is at again doing his 8-k Filings and new Share issuances (again and again)
--
In the mean time $CR

US Market News

US Market News 16分前

CORRECTED: The Illuminating Company Marks Reliability Milestone with Two New Transformers in LakewoodJune 25, 2026 8:11 PM
PR Newswire (US) Equipment supports ongoing reliability improvements to help reduce outages for customers cl

ron_66271

ron_66271 18分前

Perfect Example as to Why I Don’t Trust AI.

If AI is this superior search engine and diagnostics evaluation tool, then why didn’t Gemini site the FDIC document that the JPM payment of $1.89 Billion was based on 1% of WMB deposits of $189 Billion as a administration fee as stated by th

Real McCoy

Real McCoy 22分前

But it’s dead right?

Timing101

Timing101 22分前

Just noting the FILING posted today , many people as stated have no idea to look at the filings. NOTED.

Timing101

Timing101 25分前

I am well aware of Oscar Brito in OTC LAND, so are many others, he has/had been around on other symbols for
some time until he resigned from IQST Over Six Years Ago, the Pr from 3/4/2020
Links I always provide them
https://www.marketscreener.com/quote/stock/IQSTEL-INC-12079709

gitreal

gitreal 25分前

Today's news? Regurgitating 20 year old data by con-men??

Where's Schappert's report? What were HIS results?

againstallodds

againstallodds 27分前

tdtcal

tdtcal 27分前

It’s part of the payment for the IP in the merger. Nothing new, just paperwork from the merger.

radly

Guess this company is just worthless

Risk vs Reward

Risk vs Reward 28分前

I’ve saying all spring, don’t get worked up. Gonna be a long summer…..
Looks like with today’s news it’s gonna be a long fall/winter as well….
2027 for the 🏆
Maybe it reaches a penny again ??

zakattack

zakattack 29分前

Someone wants it has to

kairos

kairos 32分前

DTREF News ...
https://x.com/rigatoni33/status/2070295439484547319

Ascletis Pharma (PK)

Sg Etn Daily Short -3x S...

Morgan Advanced Materials

John Hancock Preferred I...

Jollibee Foods (PK)

Magellan Petroleum

South Harz Potash

Caseys General Stores

2.6% Coupon due 17sep203...

Direxion Daily TSLA Bull...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。